Prescription drug · ANDA
Sodium chloride NDC 17271-771
Sodium chloride 9 mg/mL · Injection, Solution · Intravenous · BECTON DICKINSON AND COMPANY
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 17271-771-02 | 17271077102 | 60 BAG in 1 CASE (17271-771-02) / 50 mL in 1 BAGMarketed from Nov 17, 2021 | |
| 17271-771-03 | 17271077103 | 50 BAG in 1 CASE (17271-771-03) / 100 mL in 1 BAGMarketed from Nov 17, 2021 | |
| 17271-771-05 | 17271077105 | 30 BAG in 1 CASE (17271-771-05) / 250 mL in 1 BAGMarketed from Nov 17, 2021 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Sodium chloride
- Generic name (nonproprietary)
- sodium chloride
- Active ingredients
- Sodium chloride — 9 mg/mL
- Dosage form
- Injection, Solution
- Route
- Intravenous
- Labeler
- BECTON DICKINSON AND COMPANY
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 207310
- Marketing start
- Listing expires
- Other FDA classes
- Increased Large Intestinal Motility (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Osmotic Activity (Mechanism)
- Identifiers
- Product ID 17271-771_5ad6a0d8-433f-4c8a-b8f4-7ad4ff2480e2SPL ID 5ad6a0d8-433f-4c8a-b8f4-7ad4ff2480e2SPL set ID d39b7307-df67-4e68-acb0-2eda5dc61215RxCUI 1807631, 1807632, 1807633UNII 451W47IQ8X
- Pharmacologic class
- Osmotic Laxative
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N417271077102followed by a unit qualifier and the quantityPackage 17271-0771-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Label details couldn’t be retrieved right now. Open the label on DailyMed.
Other NDCs under ANDA 207310
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Sodium chloride | Sodium chloride 9 mg/mL | Injection, SolutionIntravenous | Fresenius Kabi USA, LLC | 63323-623 |
| Sodium Chloride | Sodium chloride 9 mg/mL | Injection, SolutionIntravenous | Fresenius Kabi USA, LLC | 63323-632 |
| Sodium chloride | Sodium chloride 9 mg/mL | Injection, SolutionIntravenous | Fresenius Kabi USA, LLC | 65219-218 |
| Sodium chloride | Sodium chloride 9 mg/mL | Injection, SolutionIntravenous | Fresenius Kabi USA, LLC | 65219-220 |
| Sodium chloride | Sodium chloride 9 mg/mL | Injection, SolutionIntravenous | Fresenius Kabi USA, LLC | 65219-222 |
| Sodium chloride | Sodium chloride 9 mg/mL | Injection, SolutionIntravenous | Fresenius Kabi USA, LLC | 65219-224 |
| Sodium chloride | Sodium chloride 9 mg/mL | Injection, SolutionIntravenous | Becton Dickinson and Company | 17271-701 |
| Sodium chloride | Sodium chloride 9 mg/mL | Injection, SolutionIntravenous | Fresenius Kabi USA, LLC | 65219-282 |
| Sodium Chloride | Sodium chloride 9 mg/mL | Injection, SolutionIntravenous | Fresenius Kabi USA, LLC | 65219-328 |
| Sodium Chloride | Sodium chloride 9 mg/mL | Injection, SolutionIntravenous | Fresenius Kabi USA, LLC | 65219-432 |
| Sodium chloride | Sodium chloride 9 mg/mL | Injection, SolutionIntravenous | Fresenius Kabi USA, LLC | 65219-466 |
| 0.9% Sodium Chloridesodium chloride | Sodium chloride 9 mg/mL | Injection, SolutionIntravenous | HF Acquisition Co LLC, DBA HealthFirst | 51662-1577 |
| Sodium chloride | Sodium chloride 9 mg/mL | Injection, SolutionIntravenous | Fresenius Kabi USA, LLC | 65219-474 |
| Sodium chloride | Sodium chloride 9 mg/mL | Injection, SolutionIntravenous | Fresenius Kabi USA, LLC | 65219-468 |
| Sodium chloride | Sodium chloride 9 mg/mL | Injection, SolutionIntravenous | Fresenius Kabi USA, LLC | 65219-470 |
| Sodium chloride | Sodium chloride 9 mg/mL | Injection, SolutionIntravenous | Fresenius Kabi USA, LLC | 65219-472 |